Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences.


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
05 2020
Historique:
received: 02 05 2019
revised: 04 07 2019
accepted: 30 07 2019
pubmed: 24 8 2019
medline: 29 7 2021
entrez: 24 8 2019
Statut: ppublish

Résumé

Patients with cancer have varied preferences for involvement in decision-making. We sought older adults' preferred and perceived roles in decision-making about palliative chemotherapy; priorities; and information received and desired. Patients ≥65y who had made a decision about palliative chemotherapy with an oncologist completed a written questionnaire. Preferred and perceived decision-making roles were assessed by the Control Preferences Scale. Wilcoxon rank-sum tests evaluated associations with preferred role. Factors important in decision-making were rated and ranked, and receipt of, and desire for information was described. Characteristics of the 179 respondents: median age 74y, male (64%), having chemotherapy (83%), vulnerable (Vulnerable Elders Survey-13 score ≥ 3) (52%). Preferred decision-making roles (n = 173) were active in 39%, collaborative in 27%, and passive in 35%. Perceived decision-making roles (n = 172) were active in 42%, collaborative in 22%, and passive in 36% and matched the preferred role for 63% of patients. Associated with preference for an active role: being single/widowed (p = .004, OR = 1.49), having declined chemotherapy (p = .02, OR = 2.00). Ranked most important (n = 159) were "doing everything possible" (30%), "my doctor's recommendation" (26%), "my quality of life" (20%), and "living longer" (15%). A minority expected chemotherapy to cure their cancer (14%). Most had discussed expectations of cure (70%), side effects (88%) and benefits (82%) of chemotherapy. Fewer had received quantitative prognostic information (49%) than desired this information (67%). Older adults exhibited a range of preferences for involvement in decision-making about palliative chemotherapy. Oncologists should seek patients' decision-making preferences, priorities, and information needs when discussing palliative chemotherapy.

Identifiants

pubmed: 31439474
pii: S1879-4068(19)30190-0
doi: 10.1016/j.jgo.2019.07.026
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

626-632

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Erin B Moth (EB)

Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW, Australia; Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Electronic address: erin.moth@health.nsw.gov.au.

Belinda E Kiely (BE)

Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW, Australia; Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia; National Health and Medical Research Council, University of Sydney, Sydney, NSW, Australia.

Andrew Martin (A)

National Health and Medical Research Council, University of Sydney, Sydney, NSW, Australia.

Vasi Naganathan (V)

Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Centre for Education and Research on Ageing, Concord Repatriation General Hospital, University of Sydney, Sydney, NSW, Australia; Ageing and Alzheimer's Institute, Concord Repatriation General Hospital, Sydney, NSW, Australia.

Stephen Della-Fiorentina (S)

Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia; Southern Highlands Cancer Centre, Bowral, NSW, Australia.

Florian Honeyball (F)

Alan Coates Cancer Centre, Dubbo Base Hospital, Dubbo, NSW, Australia.

Rob Zielinski (R)

Central West Cancer Care Centre, Orange Base Hospital, Orange, NSW, Australia.

Christopher Steer (C)

Border Medical Oncology, Albury Wodonga Regional Cancer Centre, Albury, NSW, Australia.

Hiren Mandaliya (H)

Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia.

Abiramy Ragunathan (A)

Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia.

Prunella Blinman (P)

Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW, Australia; Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH